Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditary leiomyomatosis and renal cell cancer syndrome

被引:0
作者
Ono, Akihiro [1 ]
Nakamura, Masaki [1 ,7 ]
Takada, Takuya [2 ]
Miura, Sakiko [2 ]
Tsuru, Ibuki [1 ]
Izumi, Taro [1 ]
Kusakabe, Masashi [3 ]
Mitarai, Sachiko [4 ]
Nagashima, Yoji [5 ]
Kume, Haruki [6 ]
Morikawa, Teppei [2 ]
Shiga, Yoshiyuki [1 ]
机构
[1] NTT Med Ctr Tokyo, Dept Urol, Tokyo, Japan
[2] NTT Med Ctr Tokyo, Dept Diagnost Pathol, Tokyo, Japan
[3] NTT Med Ctr Tokyo, Dept Radiol, Tokyo, Japan
[4] NTT Med Ctr Tokyo, Dept Nursing, Tokyo, Japan
[5] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo, Japan
[6] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan
[7] 5-9-22 Higashigotanda,Shinagawa Ku, Tokyo 1418625, Japan
关键词
fumarate hydratase; hereditary leiomyomatosis and cancer; nephrectomy; renal cell; renal cell carcinoma; MUTATIONS; SPECTRUM;
D O I
10.1002/iju5.12688
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionPatients with hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome have high risks of uterine and cutaneous leiomyomas and renal cell carcinoma (RCC), which are caused by germline mutation of the fumarate hydratase (FH) gene. RCC lesions are mostly high-grade tumors with a poor prognosis.Case presentationA 37-year-old man who had previously undergone treatment for a left RCC was referred to our hospital with a diagnosis of right RCC. Robot-assisted partial nephrectomy was performed, and the pathological diagnosis revealed fumarate hydratase (FH)-deficient RCC. The left RCC, which was originally diagnosed as mucinous tubular and spindle cell carcinoma, was reviewed and diagnosed as FH-deficient RCC. The patient's father and uncle both died of RCC, and the father's tumor was also immunohistochemically proven to be FH-deficient RCC.ConclusionHLRCC-related RCC should be considered in a differential diagnosis of young patients with a family history of RCC.
引用
收藏
页码:144 / 147
页数:4
相关论文
共 12 条
[1]   Hereditary Leiomyomatosis and Reenal Cell Carcinoma Syndrome-associated Renal Cancer Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry [J].
Chen, Ying-Bei ;
Brannon, A. Rose ;
Toubaji, Antoun ;
Dudas, Maria E. ;
Won, Helen H. ;
Al-Ahmadie, Hikmat A. ;
Fine, Samson W. ;
Gopalan, Anuradha ;
Frizzell, Norma ;
Voss, Martin H. ;
Russo, Paul ;
Berger, Michael F. ;
Tickoo, Satish K. ;
Reuter, Victor E. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (05) :627-637
[2]   Hereditary leiomyomatosis and renal cell cancer: A syndrome associated with an aggressive form of inherited renal cancer [J].
Grubb, Robert L., III ;
Franks, Michael E. ;
Toro, Jorge ;
Middelton, Lindsay ;
Choyke, Lynda ;
Fowler, Sarah ;
Torres-Cabala, Carlos ;
Glenn, Gladys M. ;
Choyke, Peter ;
Merino, Maria J. ;
Zbar, Berton ;
Pinto, Peter A. ;
Srinivasan, Ramaprasad ;
Coleman, Jonathan A. ;
Linehan, W. Marston .
JOURNAL OF UROLOGY, 2007, 177 (06) :2074-2079
[3]   Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC) [J].
Gurruchaga Sotes, Ibon ;
Nuno Alves, Ana ;
Vicente Arregui, Sandra ;
Lobera, Carmen Santander .
CURRENT ONCOLOGY, 2021, 28 (04) :2346-2350
[4]   Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report [J].
Iribe, Yasuhiro ;
Furuya, Mitsuko ;
Shibata, Yousuke ;
Yasui, Masato ;
Funahashi, Makoto ;
Ota, Junichi ;
Iwashita, Hiromichi ;
Nagashima, Yoji ;
Hasumi, Hisashi ;
Hayashi, Narihiko ;
Makiyama, Kazuhide ;
Kondo, Keiichi ;
Tanaka, Reiko ;
Yao, Masahiro ;
Nakaigawa, Noboru .
FAMILIAL CANCER, 2021, 20 (01) :75-80
[5]   Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment [J].
Menko, Fred H. ;
Maher, Eamonn R. ;
Schmidt, Laura S. ;
Middelton, Lindsay A. ;
Aittomaki, Kristiina ;
Tomlinson, Ian ;
Richard, Stephane ;
Linehan, W. Marston .
FAMILIAL CANCER, 2014, 13 (04) :637-644
[6]   The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours [J].
Moch, Holger ;
Cubilla, Antonio L. ;
Humphrey, Peter A. ;
Reuter, Victor E. ;
Ulbright, Thomas M. .
EUROPEAN UROLOGY, 2016, 70 (01) :93-105
[7]   Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers [J].
Muller, M. ;
Ferlicot, S. ;
Guillaud-Bataille, M. ;
Le Teuff, G. ;
Genestie, C. ;
Deveaux, S. ;
Slama, A. ;
Poulalhon, N. ;
Escudier, B. ;
Albiges, L. ;
Soufir, N. ;
Avril, M-F ;
Gardie, B. ;
Saldana, C. ;
Allory, Y. ;
Gimenez-Roqueplo, A-P ;
Bressac-de Paillerets, B. ;
Richard, S. ;
Benusiglio, P. R. .
CLINICAL GENETICS, 2017, 92 (06) :606-615
[8]   Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome [J].
Raymond, Victoria M. ;
Herron, Casey M. ;
Giordano, Thomas J. ;
Gruber, Stephen B. .
FAMILIAL CANCER, 2012, 11 (01) :115-121
[9]   Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome [J].
Sanz-Ortega, Julian ;
Vocke, Cathy ;
Stratton, Pamela ;
Linehan, William Marston ;
Merino, Maria J. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (01) :74-80
[10]   Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer [J].
Tomlinson, IPM ;
Alam, NA ;
Rowan, AJ ;
Barclay, E ;
Jaeger, EEM ;
Kelsell, D ;
Leigh, I ;
Gorman, P ;
Lamlum, H ;
Rahman, S ;
Roylance, RR ;
Olpin, S ;
Bevan, S ;
Barker, K ;
Hearle, N ;
Houlston, RS ;
Kiuru, M ;
Lehtonen, R ;
Karhu, A ;
Vilkki, S ;
Laiho, P ;
Eklund, C ;
Vierimaa, O ;
Aittomäki, K ;
Hietala, M ;
Sistonen, P ;
Paetau, A ;
Salovaara, R ;
Herva, R ;
Launonen, V ;
Aaltonen, LA .
NATURE GENETICS, 2002, 30 (04) :406-410